Determining the safety, effects, and efficacy of Novus-CV in homoeopathic dilution in humans for Covid-19 disease prevention
Keywords: Adverse Events, Coronavirus, Homoeopathy, Homoeoprophylaxis (HP), Long-term Health Outcomes, Infectious Disease, Nosodes, Public Health Program
Introduction: Homoeopathic philosophy suggests nosodes can be used before, during, and after active cases for prevention and treatment.[i],[ii] The human immunological response to severe acute respiratory syndrome Covid-19 disease expression can range from mild symptoms leading to resolution, to severe symptoms leading to complete system collapse, death, or prolonged post disease conditions.[iii] The target of any disease prevention program starts with supporting immune system responses and reducing susceptibility. Homoeoprophylaxis (HP) with the Novus-CV nosode,[1],[2] aims to activate mild, disease specific, short-lived immune responses intended to facilitate the disease process and/or lessen the effects of or susceptibility to Covid-19 disease expression. The mild, short-lived immunological responses to the nosode are considered an important step in preventing disease. The collated nosode-driven symptom presentation of new and/or resolved symptoms can serve as a reference guide to the homoeopathic indications for use of the nosode in active or unresolved cases.
[1] Coronavirus was first identified in Wuhan, China, in December 2019. Thirteen samples were shipped to a third-party lab in the US for authentication. The nosode, Novus-CV, was made from samples that passed authentication. The samples were from nasopharyngeal swabs, alveolar lavage fluid, and sputum of active human cases of CV. This is a nosode made from the mutated form of the virus; one that has been passed from human to human. The nosode was potentised in the traditional way of trituration, dilution, and succussion.
[2] Nosodes are defined by the Food and Drug Administration’s (FDA) Homoeopathic Pharmacopoeia of the United States (HPUS) as homoeopathic “attenuations” of pathological organs and/or tissues, causative agents, or disease products from infected individuals, such as discharges, excretions, and secretions.
[i] Burnett J. Vaccinosis and its cure by Thuja: with remarks on Homoeoprophylaxis. Indian books & periodicals, New Delhi.
[ii] Constantine Hering Biography. 1999. [cited 2021 Feb 26]. Available from: http://www.homoeoint.org/biograph/heringen.htm.
[iii] Centers for Disease Control and Prevention. [cited 2021 Jan 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-tips-for-healthcare-providers.html.